Meeder Asset Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
GPP
FLAM
Meeder Asset Management's XENT Position: Q4 2020 in Review
Meeder Asset Management sold out of Intersect ENT, Inc (XENT) in Q4 2020, closing a stake of 89 shares — an estimated $1K sold.
Meeder Asset Management first reported a position in XENT in Q3 2015 and held it in 19 quarters. The position peaked at $432K in Q3 2015. 110 funds tracked by Wall St. Rank hold XENT as of Q4 2020.
- Meeder Asset Management reported no remaining Intersect ENT, Inc position as of Q4 2020 after selling out during the quarter.
- Meeder Asset Management sold 89 Intersect ENT, Inc shares in Q4 2020, an estimated $1K.
- Meeder Asset Management first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 19 quarters.
- Meeder Asset Management's Intersect ENT, Inc position peaked at $432K in Q3 2015.
- 110 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2020.
Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.